SYBIL DUNDON: Open Payments
NPI 1467081851 · CANTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$898 in 44 payments from 11 companies in 2025. Trend: 2023 $751 · 2024 $764 · 2025 $898
Food & beverage: $898
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $631 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $61 |
| VIVUS LLC | 2 | $36 |
| Madrigal Pharmaceuticals | 1 | $34 |
| Braintree Laboratories, Inc. | 2 | $29 |
| QOL Medical, LLC | 1 | $25 |
| Intercept Pharmaceuticals, Inc. | 1 | $22 |
| Ferring Pharmaceuticals Inc. | 1 | $17 |
| Aimmune Therapeutics, Inc. | 1 | $16 |
| Novo Nordisk Inc | 1 | $14 |
Products named: SKYRIZI, LINZESS, RINVOQ, CREON, ENTYVIO, QSYMIA, REZDIFFRA, Sucraid.
Industry payments across OH — which companies pay providers there.
